{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:39:33Z","timestamp":1769632773920,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.peptides.2021.170672","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T20:49:31Z","timestamp":1633726171000},"page":"170672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Modulatory role of PACAP and VIP on HIFs expression in lung adenocarcinoma"],"prefix":"10.1016","volume":"146","author":[{"given":"Agata Grazia","family":"D\u2019Amico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0173-4885","authenticated-orcid":false,"given":"Grazia","family":"Maugeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Maria","family":"Ras\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Reitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Saccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Magro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Velia","family":"D\u2019Agata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6 June","key":"10.1016\/j.peptides.2021.170672_bib0005","article-title":"HIF-2\u03b1 not HIF-1\u03b1 overexpression confers poor prognosis in non-small cell lung cancer","volume":"39","author":"Gao","year":"2017","journal-title":"Tumour Biol."},{"issue":"1 January","key":"10.1016\/j.peptides.2021.170672_bib0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/cells10010141","article-title":"Mimicking tumor hypoxia in non-small cell lung Cancer Employing three-dimensional in vitro models","volume":"10","author":"Zi\u00f3\u0142kowska-Suchanek","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.peptides.2021.170672_bib0015","first-page":"205","article-title":"Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit","volume":"7","author":"Gu","year":"1998","journal-title":"HIF3alpha.Gene Expr."},{"issue":"4 October","key":"10.1016\/j.peptides.2021.170672_bib0020","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1006\/bbrc.2001.5659","article-title":"Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha","volume":"287","author":"Hara","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6 June","key":"10.1016\/j.peptides.2021.170672_bib0025","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3892\/etm.2016.3193","article-title":"Expression of hypoxia-inducible factor 3\u03b1 in hepatocellular carcinoma and its association with other hypoxia-inducible factors","volume":"11","author":"Liu","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.peptides.2021.170672_bib0030","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1242\/jcs.035022","article-title":"HIF at a glance","volume":"122","author":"Brahimi-Horn","year":"2009","journal-title":"J. Cell. Sci."},{"issue":"3 June","key":"10.1016\/j.peptides.2021.170672_bib0035","first-page":"321","article-title":"Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis","volume":"36","author":"Sheng-Li","year":"2016","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"issue":"4 December","key":"10.1016\/j.peptides.2021.170672_bib0040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12031-015-0621-7","article-title":"PACAP modulates expression of hypoxia-inducible factors in streptozotocin-induced diabetic rat retina","volume":"57","author":"D\u2019Amico","year":"2015","journal-title":"J. Mol. Neurosci."},{"issue":"May","key":"10.1016\/j.peptides.2021.170672_bib0045","first-page":"139","article-title":"PACAP and VIP inhibit the invasiveness of glioblastoma cells exposed to hypoxia through the regulation of HIFs and EGFR expression","volume":"7","author":"Maugeri","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"5 May","key":"10.1016\/j.peptides.2021.170672_bib0050","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/jcp.25616","article-title":"PACAP and VIP inhibit HIF-1\u03b1-Mediated VEGF expression in a model of diabetic macular edema","volume":"232","author":"Maugeri","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"6 December","key":"10.1016\/j.peptides.2021.170672_bib0055","first-page":"619","article-title":"The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)\/glucagon superfamily","volume":"21","author":"Sherwood","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.peptides.2021.170672_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0026-895X(25)10045-X","article-title":"Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12cells","volume":"48","author":"Cavallaro","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"2 Febuary","key":"10.1016\/j.peptides.2021.170672_bib0065","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1460-9568.1996.tb01215.x","article-title":"Tissues-specific and developmenta lexpression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain","volume":"8","author":"D\u2019Agata","year":"1996","journal-title":"Eur. J. Neurosci."},{"issue":"1 Febuary","key":"10.1016\/j.peptides.2021.170672_bib0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0169-328X(97)00335-5","article-title":"Functional and molecular expression of PACAP\/VIP receptors in the rat retina","volume":"54","author":"D\u2019Agata","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"November","key":"10.1016\/j.peptides.2021.170672_bib0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2008.09.035","article-title":"PACAP and VIP prevent apoptosis in schwannoma cells","volume":"1241","author":"Castorina","year":"2008","journal-title":"Brain Res."},{"issue":"3 November","key":"10.1016\/j.peptides.2021.170672_bib0080","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s12031-012-9755-z","article-title":"Involvement of PACAP\/ADNP signaling in the resistance to cell death in malignant peripheral nerve sheath tumor (MPNST) cells","volume":"48","author":"Castorina","year":"2012","journal-title":"J. Mol. Neurosci."},{"issue":"1 March","key":"10.1016\/j.peptides.2021.170672_bib0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.yexcr.2013.11.003","article-title":"PACAP and VIP increase the expression of myelin-related proteins in rat Schwannoma cells: involvement of PAC1\/VPAC2 receptor-mediated activation of PI3K\/Akt signaling pathways","volume":"322","author":"Castorina","year":"2014","journal-title":"Exp. Cell Res."},{"issue":"3 September","key":"10.1016\/j.peptides.2021.170672_bib0090","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/pr.109.001370","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery","volume":"61","author":"Vaudry","year":"2009","journal-title":"Pharmacol. Rev."},{"issue":"1 September","key":"10.1016\/j.peptides.2021.170672_bib0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.peptides.2012.06.004","article-title":"Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin- induced diabetic rats","volume":"37","author":"Giunta","year":"2012","journal-title":"Peptides"},{"issue":"3 June","key":"10.1016\/j.peptides.2021.170672_bib0100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/bph.12181","article-title":"VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair","volume":"169","author":"Waschek","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"1 Febuary","key":"10.1016\/j.peptides.2021.170672_bib0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MED.0000000000000218","article-title":"Vasoactive intestinal peptide\/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer","volume":"23","author":"Moody","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"3 November","key":"10.1016\/j.peptides.2021.170672_bib0110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0167-0115(91)90071-N","article-title":"Pituitary adenylate cyclase activating peptide (PACAP) in guinea-pig lung: distribution and dilatory effects","volume":"36","author":"Cardell","year":"1991","journal-title":"Regul. Pept."},{"issue":"1","key":"10.1016\/j.peptides.2021.170672_bib0115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000236498","article-title":"Peptide-containing nerve fibers in human airways: distribution and coexistencepattern","volume":"101","author":"Luts","year":"1993","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"2 August","key":"10.1016\/j.peptides.2021.170672_bib0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1183\/09031936.99.14244399","article-title":"Bronchodilation by pituitary adenylate cyclase-activating peptide and related peptides","volume":"14","author":"Lind\u00e9n","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.peptides.2021.170672_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004080000043","article-title":"The induction of carbon monoxide-mediated airway relaxation by PACAP 38 in isolated guinea pig airways","volume":"179","author":"Kinhult","year":"2001","journal-title":"Lung"},{"issue":"3 March","key":"10.1016\/j.peptides.2021.170672_bib0130","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pharmthera.2008.11.006","article-title":"VPAC and PAC receptors: from ligands to function","volume":"121","author":"Dickson","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"1 May","key":"10.1016\/j.peptides.2021.170672_bib0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","article-title":"Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1","volume":"166","author":"Harmar","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"4 April","key":"10.1016\/j.peptides.2021.170672_bib0140","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3892\/ijo.2014.2276","article-title":"Vasoactive intestinal peptide receptor-based imaging and treatment of tumors (Review)","volume":"44","author":"Tang","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"3 November","key":"10.1016\/j.peptides.2021.170672_bib0145","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1432-1033.1990.tb19392.x","article-title":"Binding sites of a novel neuropeptide pituitary-adenylate-cyclase-activating polypeptide in the rat brain and lung","volume":"193","author":"Lam","year":"1990","journal-title":"Eur. J. Biochem."},{"issue":"6 June","key":"10.1016\/j.peptides.2021.170672_bib0150","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1210\/endo-128-6-3055","article-title":"Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions","volume":"128","author":"Shivers","year":"1991","journal-title":"Endocrinology."},{"key":"10.1016\/j.peptides.2021.170672_bib0155","first-page":"387","article-title":"Immunohistochemical localization of receptors for vasoactive intestinal peptide and substance P in human trachea","volume":"67","author":"Fischer","year":"1992","journal-title":"Lab. Invest."},{"issue":"4 April","key":"10.1016\/j.peptides.2021.170672_bib0160","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0896-6273(92)90101-I","article-title":"Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide","volume":"8","author":"Ishihara","year":"1992","journal-title":"Neuron."},{"key":"10.1016\/j.peptides.2021.170672_bib0165","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0196-9781(93)90154-9","article-title":"Interaction of ovine pituitary adenylate cyclase activating peptide (PACAP-38) with rat lung membranes","volume":"14","author":"Bitar","year":"1993","journal-title":"Peptides"},{"issue":"6 December","key":"10.1016\/j.peptides.2021.170672_bib0170","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1210\/endo.135.6.7988457","article-title":"Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions","volume":"135","author":"Usdin","year":"1994","journal-title":"Endocrinology"},{"issue":"2 March-April","key":"10.1016\/j.peptides.2021.170672_bib0175","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0196-9781(93)90036-G","article-title":"Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells","volume":"14","author":"Moody","year":"1993","journal-title":"Peptides"},{"issue":"21 November","key":"10.1016\/j.peptides.2021.170672_bib0180","first-page":"4886","article-title":"Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells","volume":"55","author":"Zia","year":"1995","journal-title":"Cancer Res."},{"issue":"3 March","key":"10.1016\/j.peptides.2021.170672_bib0185","first-page":"1214","article-title":"Secretin\/VIP stimulated secretion of bombesin-like peptides from human SCLC","volume":"46","author":"Korman","year":"1986","journal-title":"Cancer Res."},{"issue":"10 May","key":"10.1016\/j.peptides.2021.170672_bib0190","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1073\/pnas.90.10.4345","article-title":"A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth","volume":"90","author":"Moody","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3 March","key":"10.1016\/j.peptides.2021.170672_bib0195","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0196-9781(03)00058-5","article-title":"VIP and PACAP receptors coupled to adenylyl cyclase in human lung cancer: a study in biopsy specimens","volume":"24","author":"Busto","year":"2003","journal-title":"Peptides."},{"issue":"1 July","key":"10.1016\/j.peptides.2021.170672_bib0200","first-page":"L42","article-title":"Expression, pharmacological, and functional evidence for PACAP\/VIP receptors in human lung","volume":"277","author":"Busto","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"2 Febuary","key":"10.1016\/j.peptides.2021.170672_bib0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0196-9781(99)00202-8","article-title":"Immunohistochemical localization and distribution of VIP\/PACAP receptors in human lung","volume":"21","author":"Busto","year":"2000","journal-title":"Peptides"},{"issue":"3 November","key":"10.1016\/j.peptides.2021.170672_bib0210","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12031-014-0335-2","article-title":"NAP reduces murine microvascular endothelial cells proliferation induced by hyperglycemia","volume":"54","author":"D\u2019Amico","year":"2014","journal-title":"J. Mol. Neurosci."},{"issue":"7 July","key":"10.1016\/j.peptides.2021.170672_bib0215","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1007\/s13277-015-3166-z","article-title":"Expression pattern of parkin isoforms in lung adenocarcinomas","volume":"36","author":"D\u2019Amico","year":"2015","journal-title":"Tumour Biol."},{"issue":"2 Febuary","key":"10.1016\/j.peptides.2021.170672_bib0220","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12031-016-0869-6","article-title":"Nap interferes with hypoxia-inducible factors and VEGF expression in retina of diabetic rats","volume":"61","author":"D\u2019Amico","year":"2017","journal-title":"J. Mol. Neurosci."},{"issue":"10 October","key":"10.1016\/j.peptides.2021.170672_bib0225","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1046\/j.1460-9568.2000.00244.x","article-title":"Regional and cellular expression of the parkin gene in the rat cerebral cortex","volume":"12","author":"D\u2019Agata","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2021.170672_bib0230","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0196-9781(87)90143-4","article-title":"High affinity binding of VIP to human lung cancer cell lines","volume":"8","author":"Shaffer","year":"1987","journal-title":"Peptides"},{"issue":"6 November-December","key":"10.1016\/j.peptides.2021.170672_bib0235","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0196-9781(90)90153-V","article-title":"VIP binds with high affinity to NSCLC cells and elevates cAMP levels","volume":"11","author":"Lee","year":"1990","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170672_bib0240","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0031-6997(24)01360-7","article-title":"Nomenclature of receptors for VIP and PACAP","volume":"50","author":"Harmar","year":"1998","journal-title":"Pharmacol. Rev."},{"issue":"3 November","key":"10.1016\/j.peptides.2021.170672_bib0245","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12031-012-9815-4","article-title":"PACAP immunoreactivity in human malignant tumor samples and cardiac diseases","volume":"48","author":"Szanto","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.peptides.2021.170672_bib0250","first-page":"1846","article-title":"In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging","volume":"36","author":"Reubi","year":"1995","journal-title":"J. Nucl. Med."},{"issue":"4 October","key":"10.1016\/j.peptides.2021.170672_bib0255","first-page":"1019","article-title":"Gene expression of vasoactive intestinal peptide receptors in human lung cancer","volume":"39","author":"Szilasi","year":"2011","journal-title":"Int. J. Oncol."},{"issue":"11 June","key":"10.1016\/j.peptides.2021.170672_bib0260","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3390\/cancers13112813","article-title":"An overview of the recent development of anticancer agents targeting the HIF-1","volume":"13","author":"Shirai","year":"2021","journal-title":"Transcription FactorCancers (Basel)."},{"issue":"7 July","key":"10.1016\/j.peptides.2021.170672_bib0265","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.neo.2021.05.013","article-title":"Reduction in mitochondrial oxidative stress mediates hypoxia-induced resistance to cisplatin in human transitional cell carcinoma cells Neoplasia","volume":"23","author":"Kim","year":"2021","journal-title":"Neoplasia"},{"issue":"3 June","key":"10.1016\/j.peptides.2021.170672_bib0270","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1139\/bcb-2016-0197","article-title":"Differential effect of hypoxia and acidity on lung cancer cell and fibroblast metabolism","volume":"95","author":"Giatromanolaki","year":"2017","journal-title":"Biochem. Cell Biol."},{"issue":"1-3 Febuary","key":"10.1016\/j.peptides.2021.170672_bib0275","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.regpep.2008.12.003","article-title":"Vasoactive intestinal peptide enhances wound healing and proliferation of human bronchial epithelial cells","volume":"153","author":"Guan","year":"2009","journal-title":"Regul. Pept."},{"issue":"December","key":"10.1016\/j.peptides.2021.170672_bib0280","first-page":"389","article-title":"VIP inhibits the proliferation of SCLC and NSCLC","volume":"805","author":"Maruno","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121001807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121001807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:32:35Z","timestamp":1759311155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978121001807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":56,"alternative-id":["S0196978121001807"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170672","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulatory role of PACAP and VIP on HIFs expression in lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170672"}}